In Melanoma Sensitive To MEK Inhibitor Drug Therapy a Rare BRAF Mutation Detected

Rare mutation of the BRAF gene in people with melanoma has been noted to respond to MEK inhibitor drugs, offering a rationale for routine screening and therapy in melanoma patients who hold the BRAF L597 mutation. The new study by co-first-authors Kimberly Brown Dahlman, Ph.D., Junfeng Xia, Ph.D., and Katherine Hutchinson, B.S., Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., was published online July 14 in iCancer Discovery/i. The research was led ...

via Medindia Health News More READ